Evidence map›Paper›PMID 40629416›Full record

ArticleJournal of health, population, and nutrition2025

Global trends in polycystic ovarian syndrome over 30 years: an age-period-cohort study of 204 countries and territories (1990-2021).

Lanxiang Lin, Wenhui Li, Baozhu Xu, Yuefeng Li, Jin Li, Xiangjun Kong, Xin Du

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lanxiang Lin *Health Management Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Wenhui Li *Health Management Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Baozhu XuHealth Management Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Yuefeng LiHealth Management Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Jin LiHealth Management Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Xiangjun KongIntravenous Drug Dispensing Centre, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Xin DuDepartment of Ultrasound, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China. duxin20070821@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo characterize global temporal trends in the incidence of polycystic ovary syndrome (PCOS) from 1990 to 2021 by applying an age-period-cohort (APC) analytical framework across 204 countries and territories, and to assess how these incidence patterns vary according to socio-demographic context.

methodsThis study analyzed PCOS incidence trends from 1990 to 2021 across 204 countries using an APC analysis. Data were sourced from the Global Burden of Disease Study 2021, focusing on crude and age-standardized incidence rates, disaggregated by region and socio-demographic index (SDI).

resultsThe global incidence of PCOS increased from 1.48 million cases in 1990 to 2.3 million in 2021. The age-standardized incidence rate in 2021 was 63.26 per 100,000 population (95% CI: 45.41 to 87.28). High SDI regions recorded the highest incidence rates, with a rate of 90.13 per 100,000 (95% CI: 66.94 to 122.36). In contrast, low SDI regions had the lowest incidence rates at 36.8 per 100,000 (95% CI: 25.83 to 52.19). The APC model revealed a global net drift of 0.18 (95% CI: -0.02 to 0.37), with significant age and period effects, particularly among younger age groups.

conclusionThis APC analysis reveals marked increases in global PCOS incidence driven by adolescent age groups, mid-2000s period effects, and recent birth cohorts. Findings underscore the need for age- and cohort-targeted interventions and harmonized diagnostics to address the growing PCOS burden.

Indexed as

Global HealthPolycystic Ovary SyndromeAdolescentAdultAge FactorsCohort StudiesFemaleGlobal Burden of DiseaseHumansIncidenceMiddle AgedSocioeconomic FactorsYoung AdultAge-period-cohortGlobal burden of disease studyGlobal healthIncidencePolycystic ovary syndrome

Identifiers

PMID40629416
PMCPMC12239280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.